Evaluation of the Impact of Hematocrit and Other Interference on the Accuracy of Hospital-Based Glucose Meters
- 1 April 2008
- journal article
- research article
- Published by Mary Ann Liebert Inc in Diabetes Technology & Therapeutics
- Vol. 10 (2), 111-120
- https://doi.org/10.1089/dia.2007.0257
Abstract
Background: Most glucose meter comparisons to date have focused on performance specifications likely to impact subcutaneous dosing of insulin. We evaluated four hospital-based glucose meter technologies for accuracy, precision, and analytical interferences likely to be encountered in critically ill patients, with the goal of identifying and discriminating glucose meter performance specifications likely to impact intensive intravenous insulin dosing. Methods: Precision, both within-run and day-to-day, was evaluated on all four glucose meters. Accuracy (bias) of the meters and analytical interference were evaluated by comparing results obtained on whole blood specimens to plasma samples obtained from these whole blood specimens run on a hexokinase reference method. Results: Precision was acceptable and differed little between meters. There were significant differences in the degree to which the meters correlated with the reference hexokinase method. Ascorbic acid showed significant interference with three of the four meters. Hematocrit also affected the correlation between whole blood and plasma hexokinase glucose on three of the four glucose meters tested, with the magnitude of this interference also varying by glucose meter technology. Conclusions: Correlation to plasma hexokinase values and hematocrit interference are the main variables that differentiate glucose meters. Meters that correlate with plasma glucose measured by a reference method over a wide range of glucose concentrations and minimize the effects of hematocrit will allow better glycemic control for critically ill patients.Keywords
This publication has 18 references indexed in Scilit:
- Accuracy of Roche Accu-Chek Inform Whole Blood Capillary, Arterial, and Venous Glucose Values in Patients Receiving Intensive Intravenous Insulin Therapy After Cardiac SurgeryAmerican Journal of Clinical Pathology, 2007
- Glucose Measurement: Confounding Issues in Setting Targets for Inpatient ManagementDiabetes Care, 2007
- Accuracy evaluation of a new glucometer with automated hematocrit measurement and correctionClinica Chimica Acta; International Journal of Clinical Chemistry, 2005
- Intensive Insulin Therapy for Critically III PatientsAnnals of Pharmacotherapy, 2004
- Performance Evaluation of Blood Glucose Monitoring DevicesDiabetes Technology & Therapeutics, 2003
- Intensive Insulin Therapy in Critically Ill PatientsNew England Journal of Medicine, 2001
- Oxygen effects on glucose meter measurements with glucose dehydrogenase- and oxidase-based test strips for point-of-care testingCritical Care Medicine, 2001
- Quality Specifications for Glucose Meters: Assessment by Simulation Modeling of Errors in Insulin DoseClinical Chemistry, 2001
- Oxygen Effects on Glucose Measurements with a Reference Analyzer and Three Handheld MetersDiabetes Technology & Therapeutics, 2000
- Effects of Drugs on Glucose Measurements With Handheld Glucose Meters and a Portable Glucose AnalyzerAmerican Journal of Clinical Pathology, 2000